[1] Yang YY, Lin HC. The heart: pathophysiology and clinical implications of cirrhotic cardiomyopathy[J]. J Chin Med Assoc, 2012, 75(12):619-623. [2] Zardi EM, Abbate A, Zardi DM, et al. Cirrhotic cardiomyopathy [J]. J Am Coll Cardiol, 2010,10(8):539-549. [3] Glenn TK,Honar H, Liu H, et al. Role of cardiac myofilament proteins titin and collagen in the pathogenesis of diastolic dysfunction in cirrhotic rats[J].Hepatology,2011,55(12):1249-1255. [4] 高扬,李国杰. 肝硬化性心肌病研究[J]. 医学综述,2008,1(14): 273-275. [5] 陈峰松,赵建妹.肝硬化心肌病研究进展[J]. 中国临床新医学, 2009,1(2):102-105. [6] Locher MR, Razumova MV, Stelzer JE,et al.Effects of low-level α-myosin heavy chain expression on contractile kinetics in porcine myocardium [J]. Am J Physiol Heart Circ Physiol,2011,300(3):869-878. [7] Izumo S,Lompre AM,Matsuoka R,et al.Myosin heavy chain messenger RNA and protein isoform transitions during cardiac hypertrophy. Interaction between hemodynamic and thyroid hormone-induced signals [J]. J Clin Invest,1987,79(3):970-975. [8] Brooks WW, Bing OH, Blaustein AS, et al.Comparison of contractile state and Myosin isozymes of rat and left ventricular myocardium[J]. J Mol Cell Cardiol,1987,19(5):433-440. [9] James J, Hor K, Moga MA,et al.Effects of myosin heavy chain manipulation in experimental heart failure[J]. J Mol Cell Cardiol,2010,48(5):999-1006. |